Immediate Impact
67 standout
Citing Papers
Emerging and Re-emerging Warheads for Targeted Covalent Inhibitors: An Update
2024 Standout
Datopotamab Deruxtecan in Advanced or Metastatic HR+/HER2– and Triple-Negative Breast Cancer: Results From the Phase I TROPION-PanTumor01 Study
2024 Standout
Works of Simon Corbett being referenced
ADCT-402, a PBD dimer–containing antibody drug conjugate targeting CD19-expressing malignancies
2018
hLL2-Cys-PBD, a New Site-Specifically Conjugated, Pyrrolobenzodiazepine (PBD) Dimer-Based Antibody Drug Conjugate (ADC) Targeting CD22-Expressing B-Cell Malignancies.
2016
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Simon Corbett | 293 | 95 | 71 | 159 | 12 | 359 | |
| Warak Chaovapong | 122 | 111 | 41 | 310 | 10 | 404 | |
| S. E. Owens | 121 | 66 | 16 | 85 | 13 | 324 | |
| Josefa Chuh | 260 | 137 | 23 | 245 | 9 | 390 | |
| Jerry Shevitz | 97 | 149 | 13 | 262 | 17 | 394 | |
| Robin Goldman-Leikin | 100 | 78 | 11 | 203 | 13 | 335 | |
| Anja Schmid | 115 | 149 | 58 | 72 | 14 | 310 | |
| A. Guclu | 121 | 148 | 24 | 233 | 18 | 378 | |
| Steven M. Schmid | 132 | 192 | 61 | 56 | 14 | 385 | |
| Don K. Hamlin | 69 | 65 | 37 | 318 | 12 | 395 | |
| Shigeyuki Iijima | 156 | 185 | 23 | 113 | 9 | 371 |
All Works
Login with ORCID to disown or claim papers
Loading papers...